About
Media
Videos
Branches
Novartis
Key Trials
4 trials shown
Novartis
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC
The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with
- Trial number:
- NCT04720157
- Trial phase:
- 3
- Overall status:
- Recruiting
- Study type:
- Local/Regional therapies, Chemotherapy
Novartis
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
This is a phase Ib/II open label study. The escalation part will characterize the safety and tolerability of JDQ443 single agent and JDQ443 in combination with the other study trea
- Trial number:
- NCT04699188
- Trial phase:
- 1, 2
- Overall status:
- Recruiting
- Study type:
- Targeted therapy, Biomarker
Novartis
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
The purpose of the First-In-Human study is to assess safety, tolerability, pharmacokinetics (PK), immunogenicity and preliminary efficacy of JBH492 as single agent.
- Trial number:
- NCT04240704
- Trial phase:
- 1
- Overall status:
- Recruiting
- Study type:
- Chemotherapy, Targeted therapy
Novartis
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
The purpose of this first in human (FIH) trial is to characterize the safety and tolerability of the SHP2 inhibitor TNO155 alone and in combination with EGF816 (nazartinib) and ide
- Trial number:
- NCT03114319
- Trial phase:
- 1
- Overall status:
- Recruiting
- Study type:
- Targeted therapy, Biomarker